Vitiligo Market Research
What is Vitiligo?
Vitiligo is a long-term skin condition in which patches of skin lose color or pigment. Melanocytes produce the pigment known as melanin, which gives skin its color and protects against UV rays. In patients with vitiligo, the body’s immune system destroys the melanocytes, causing a lack of melanin in the skin. While vitiligo can affect people of any age, gender or ethnicity, it most commonly affects younger people.
There are two common types of vitiligo: nonsegmental vitiligo and segmental vitiligo. Nonsegmental vitiligo is the most common form, which occurs when there are scattered patches of color loss present all over the body. Segmental vitiligo on the other hand, usually only affects one side of the body.
Currently, Opzelura is the only treatment available to treat nonsegmental vitiligo. Other medications, phototherapies and laser therapies are also used to help restore some color in these patients.
Spherix Global Insights – Dermatology – Vitiligo
Spherix Global Insights’ Dermatology therapeutic team is a leading provider of independent syndicated vitiligo market research, insights, business intelligence & advisory services.
Spherix’s Dermatology team covers studies publishing this year in their Market Dynamix™ and Launch Dynamix™ services including:
- Market Dynamix™: Vitiligo (US)
- Launch Dynamix™: Opzelura (Incyte) in Vitiligo (US)
Spherix’s Market Dynamix™ service is based on dermatologists and key opinion leader feedback in the form of surveys and qualitative interviews. The reports consist of an analysis of markets anticipated to experience a paradigm shift within 3-5 years. Insights highlight market size, current treatment approaches, unmet needs, and expert opinions on the likely disruption introduced by pipeline agents.
Spherix’s Launch Dynamix™ service consists of two parts: monthly KPI tracking and quarterly deep dives. Monthly KPIs provide monthly benchmarking of newly launched products which includes for the first eighteen months of commercial availability, and quarterly deep dive reports includes promotional activity, barriers to uptake, and patient types gravitating to the launch brand.
Follow Spherix Dermatology on Social Media
Follow us for dermatology industry news, insights & analysis:
Twitter: https://twitter.com/SpherixDerm
LinkedIn: https://www.linkedin.com/company/spherix-global-insights/
For Guests & Current Clients
For more details on Spherix’s primary market research reports and interactive dashboard offerings, visit or register here: https://clientportal.spherixglobalinsights.com
